Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K955897
    Manufacturer
    Date Cleared
    1996-08-05

    (223 days)

    Product Code
    Regulation Number
    866.3220
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The TechLab Crypto/Giardia-Cel IF Test can be used to detect Cryptosporidium oocysts and Giardia cysts in fecal specimens from persons suspected of having intestinal disease due to these pathogens.

    Device Description

    The kit, which includes ready-to-use reagents, contains an antibody reagent consisting of a mixture of FITC-labeled anti-Cryptosporidium monoclonal antibody and FITC-labeled anti-Giardia monoclonal antibody. These antibodies function as the detecting antibodies. The monoclonal antibodies are prepared from mouse ascites fluid. The antibodies against Giardia are the same as those used in the Giardia-Cel IF Test (K912152), which has been cleared for in vitro diagnostic use.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study for the TechLab Crypto/Giardia-Cel IF Test:

    While the provided text describes the device and its intended use, it does not explicitly state specific numerical acceptance criteria for performance metrics like sensitivity, specificity, or accuracy. Instead, it focuses on demonstrating "substantial equivalence" to existing cleared devices by showing a "correlation of 100%." This implies that the acceptance criteria are met if the new test performs identically to already approved tests.

    Here's the information extracted and organized based on your request:

    Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Substantial equivalence to approved immunofluorescent test specific for Cryptosporidium and Giardia (Merifluor Cryptosporidium/Giardia Direct Immunofluorescent Detection Procedure).100% correlation with the Merifluor Cryptosporidium/Giardia Direct Immunofluorescent Detection Procedure in two studies for the detection of Cryptosporidium oocysts and Giardia cysts in fecal specimens.
    Substantial equivalence to the Giardia-Cel IF Test (approved for in vitro diagnostic use) and the Crypto-Cel IF Test (510(k) application submitted).100% correlation with the Giardia-Cel IF Test and the Crypto-Cel IF Test in one of the studies.

    Study Details

    1. Sample size used for the test set and the data provenance:

      • The text does not specify the exact sample size used for the test set in either of the two studies.
      • Data Provenance: The text does not explicitly state the country of origin or whether the data was retrospective or prospective. It refers to "clinical evaluations," which typically suggests patient samples, but further details are not provided.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • The text does not mention the use of experts to establish ground truth or their qualifications. The ground truth appears to be established by comparison with existing cleared diagnostic tests.
    3. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

      • The text does not describe an adjudication method. The study design is a head-to-head comparison with established tests, implying the results of the comparator tests served as a reference.
    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No, an MRMC comparative effectiveness study was not done. This device is an in-vitro diagnostic (IVD) test, not an AI-powered image analysis tool. The study focuses on the performance of the test itself, not on human reader improvement with AI assistance.
    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

      • Yes, a standalone performance assessment was effectively done. The study compared the TechLab Crypto/Giardia-Cel IF Test directly against other diagnostic tests. The "performance" being measured is the inherent capability of the test reagents and methodology to detect the pathogens, independent of human interpretation variability once the fluorescence is observed.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • The ground truth was established by comparison with FDA-cleared and submitted diagnostic tests (Merifluor Cryptosporidium/Giardia Direct Immunofluorescent Detection Procedure, Giardia-Cel IF Test, and Crypto-Cel IF Test). The assumption is that these comparator tests accurately identify the presence of Cryptosporidium oocysts and Giardia cysts.
    7. The sample size for the training set:

      • The text does not refer to a "training set" as this is a traditional laboratory diagnostic test rather than a machine learning algorithm. Therefore, no sample size for a training set is mentioned or applicable in this context.
    8. How the ground truth for the training set was established:

      • As no "training set" is applicable for this type of IVD, this question is not relevant to the provided information.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1